Optical coherence tomography has transformed ophthalmic imaging, but even OCT has limits. Strong scattering in biological tissue reduces imaging depth, lowers contrast, and introduces noise that can blur or obscure fine structures. A review in the Journal of Biomedical Optics argues that spatio-temporal optical coherence imaging – and its volumetric extension, spatio-temporal optical coherence tomography (STOC-T) – may offer a route past some of these long-standing barriers.
The central idea is deceptively simple: rather than trying to clean up noisy images after acquisition, STOC-T changes the way light is delivered and detected. By dynamically modulating the spatial phase of illumination and combining this with interferometric detection and spectral sweeping, the technique preferentially preserves ballistic or minimally scattered photons while suppressing multiply scattered light. In practical terms, it attempts to keep the signal that carries true structural information and average away the light that contributes to optical crosstalk.
Conventional OCT and confocal approaches often face a trade-off between lateral resolution and imaging depth. Improving one can compromise the other, particularly when trying to resolve deeper ocular structures such as the choroid. STOC-T uses full-field detection, controlled coherence, and computational correction of defocus and aberrations to maintain high-resolution imaging across an extended depth range.
The review highlights several in vivo applications with particular relevance to eye care. In retinal imaging, STOC-T has enabled high-contrast visualization of the retina–choroid complex, including en face and cross-sectional views across a wide field. The technique has been used to visualize the hyaloid membrane, retinal nerve fiber layer, ganglion cell layer, choroidal structures, photoreceptor mosaics, and retinal ganglion cell soma. It has also supported angio-STOC-T reconstructions of retinal vasculature, showing capillary plexuses and superficial retinal vessels, and has been applied to blood flow analysis through Doppler-based approaches.
Corneal imaging represents another promising area. Contact confocal microscopy can provide cellular-level en face images, but it requires physical contact, topical anesthesia, and a cooperative patient. STOC-T, by contrast, is non-contact. The review describes in vivo corneal imaging in which multiple corneal layers were resolved, including the epithelium, sub-basal nerve plexus, stroma, keratocytes, and endothelium. Following computational correction, cellular-level microstructure became clearer, and endothelial cell density and morphometric analysis showed agreement with conventional specular microscopy.
The technique may also contribute to functional retinal imaging. STOC-T has been used in optoretinography, measuring light-evoked optical changes in photoreceptors. Its combination of speed, contrast, and phase stability may help capture rapid retinal dynamics and link optical signals more closely to photoreceptor physiology.
The review does not overstate the clinical readiness of the technology. STOC-T produces large datasets and depends on high-speed cameras, substantial bandwidth, and computationally intensive post-processing. These practical burdens must be reduced before widespread clinical adoption. System design also remains a balancing act: stronger coherence suppression can improve crosstalk rejection but may introduce trade-offs in imaging range, complexity, or light efficiency.
Even so, the message is cogent. STOC-T does not simply make OCT images prettier; it tackles the physics of scattering at the measurement stage. If future systems can streamline acquisition and processing, STOC-T could become a powerful addition to ophthalmic diagnostics, offering deeper, higher-contrast, cellular-level views of the retina, choroid, and cornea without contact and without sacrificing resolution.
